CLINICAL QUALIFICATION OF DNA REPAIR DEFECTS AS BIOMARKERS IN METASTATIC PROSTATE CANCER USING INTEGRATED GENOMICS AND TISSUE-BASED FUNCTIONAL ASSAYS
$658,770FY2018Defense Health AgencyDOD
Fundacio Privada Institut D Investigacio Oncologica De Vall-Hebron